Skip to main content
. 2011 Sep 8;6(9):e24459. doi: 10.1371/journal.pone.0024459

Table 2. Comparisons of patient co-morbidities between AMA and non-AMA groups.

Patient co-morbidities AMA(n = 328) Non-AMA(n = 328) p-value
Neurologic Conditions 71 (22%) 22 (7%) <0.001
Alcoholism 93 (28%) 42 (13%) <0.001
Gastrointestinal bleeding 45 (14%) 11 (3%) <0.001
Psychiatric illness 86 (26%) 46 (14%) <0.001
Soft-tissue infections 155 (47%) 75 (23%) <0.001
HCV 201 (61%) 122 (37%) <0.001
HIV 111 (34%) 96 (29%) 0.07
Diabetes 19 (6%) 32 (10%) 0.07
COPD 44 (13%) 38 (12%) 0.46
CHF 10 (3%) 11 (3%) 1
Injection Drug Use 178 (54%) 76 (23%) <0.001
Number of co-morbidities (median, IQR) 4 (3, 5) 2 (1, 3) <0.001
0–1 31 (9.5%) 134 (40.9%)
2–3 73 (22.3%) 117 (35.7%)
≥4 224 (68.3%) 77 (23.5%)

HCV = hepatitis C virus; COPD = chronic obstructive pulmonary disease; CHF = congestive heart failure.